Similar to Ghanim et al.15, who reported that dapagliflozin reduced hepcidin in patients with diabetes, and with findings from DAPA-HF20, hepcidin levels tended to decrease with empagliflozin in EMPATROPISM-FE. The gene discussed is HAMP; the disease is diabetes mellitus.